Amiloride, a Specific Drug for Hypertension in Black People With T594M Variant?
Emma H. Baker(St George's, University of London), Graham A. MacGregor(Queen Mary University of London), Nicola J. Ireson(St George's Hospital), Yanbin Dong(St George's Hospital), Nirmala D. Markandu(University of London), Monique Wood(St George's Hospital), Ajay Duggal(St George's Hospital)
Cited by 95
Related Papers
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
|The Lancet Diabetes & Endocrinology|2018|340
DOUBLE-BLIND STUDY OF THREE SODIUM INTAKES AND LONG-TERM EFFECTS OF SODIUM RESTRICTION IN ESSENTIAL HYPERTENSION
|The Lancet|1989|272
Structural Skin Capillary Rarefaction in Essential Hypertension
|Hypertension|1999|259